Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 18/20 | 0.55 |
| ▸ | PDE3A | Q14432 | 14/20 | 0.55 |
| ▸ | PDE4A | P27815 | 5/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.32 |
| ▸ | CHRNE | Q04844 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13304142 | 0.95 | PDE4B (0.52) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3122872 | 0.87 | PDE4B (0.71) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3117923 | 0.87 | PDE4B (0.57) | PDE4BPDE3A | |
| SCHEMBL3123497 | 0.84 | PDE4B (0.52) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3117860 | 0.84 | PDE4B (0.58) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3116884 | 0.84 | PDE4B (0.50) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3111460 | 0.83 | PDE4B (0.49) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3121108 | 0.83 | PDE4B (0.54) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL2845455 | 0.83 | PDE4B (0.77) | PDE4BPDE3APDE4APDE4CPDE4D | |
| SCHEMBL3123512 | 0.83 | PDE4B (0.49) | PDE4BPDE3APDE4APDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100160335-A1 | PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT | KYORIN PHARMACEUTICAL CO., LTD. | 2010-06-24 | — | — | US | disclosed |
| EP-2168959-A1 | PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT | Kyorin Pharmaceutical Co., Ltd. (JP) | 2010-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160335-A1 | PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT | PDE3A, PDE5A, PDE2A | PDE4B 8/4885PDE3A 1/4885PDE4A 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.